BRC Therapeutics
PrivateLast Round
Series A
Oct 4, 2022
Total Funding Raised
$23M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
BRC Therapeutics operates in Healthcare & Life Sciences and is based in Castroville, California. Its latest recorded funding round was a Series A round in October 2022.
BRC Therapeutics is a biopharmaceutical company that develops cannabinoid-based prescription medicines for the treatment of pain and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BRC Therapeutics Comparables
Compare BRC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Groff North America | 84% | |
| Maridose LLC | 83% | |
| Royal Emerald Pharmaceuticals | 80% |
For institutional investors. Book with your work email.
BRC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 4, 2022 | ||||
| Convertible Debt | Oct 2, 2020 |
For institutional investors. Book with your work email.
BRC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Achari Ventures | Series A |
| Intrinsic Capital Partners | Series A |
| Delta Emerald Ventures | Series A |
| AFI Capital Partners | Series A |
| Argonautic Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2026
Kimberly Spancake appointed Senior Director, Clinical.
- May 14, 2025
Dr. Stephen Wright joins as Advisor in Drug Development.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 5, 2026
BRC Therapeutics hires Kimberly Spancake, who brings clinical operations experience from GW Pharmaceuticals and Jazz Pharmaceuticals to strengthen the company’s clinical execution as its programs grow.
- hiresNov 5, 2026
BRC Therapeutics appoints Kimberly Spancake as Senior Director, Clinical in California on Nov 5th '26, where she leads clinical operations across the company’s development programs.
- attends_eventSep 28, 2026
BRC Therapeutics announced its participation in the Regulatory Perspectives on Herbal Medicinal/Botanical Drug Product Development workshop, convened jointly by the FDA and EMA in the Netherlands, on Sep 28th '26.
- hiresAug 24, 2026
BRC Therapeutics appoints Chandra Ramanathan as Executive Vice President of Commercialization and Strategy in California on Aug 24th '26, as the clinical-stage pharmaceutical company advances its pipeline and prepares for its next phase of growth.
- attends_eventAug 11, 2026
BRC Therapeutics's Founder and CEO George Hodgin is to participate in a fireside chat at Nucleate Global Summit 2026, taking place in Aug '26 at Southfork Ranch in Texas.
For institutional investors. Book with your work email.
BRC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BRC Therapeutics's valuation, stock price, and market status.
Is BRC Therapeutics a public or private company?
BRC Therapeutics is a private company.
What is the current stock price of BRC Therapeutics?
BRC Therapeutics is a private company, so its shares have no public market price. Caplight tracks BRC Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BRC Therapeutics worth (valuation)?
Valuation information for BRC Therapeutics is not publicly available.
Can I buy BRC Therapeutics stock?
BRC Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BRC Therapeutics's last funding round?
BRC Therapeutics's most recent funding round was Series A on October 4, 2022.
Who are the main investors in BRC Therapeutics?
Key investors in BRC Therapeutics include Intrinsic Capital Partners.
Will BRC Therapeutics IPO soon?
No public IPO plans have been announced for BRC Therapeutics.
How can I track BRC Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in BRC Therapeutics's shares on secondary markets.